Last reviewed · How we verify
NCT04762056
CPAx for Assessing Functional Status of COVID-19 Patients After Intensive Care Unit Discharge
trial testing Chelsea Critical Care Physical Assessment Tool in Post Intensive Care Unit Syndrome in 16 participants. Completed in 30 May 2021.
30 May 2021
Quick facts
| Lead sponsor | Gaziosmanpasa Research and Education Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 16 |
| Start date | 22 February 2021 |
| Primary completion | 30 May 2021 |
| Estimated completion | 30 May 2021 |
| Sites | 2 locations across Turkey (Türkiye) |
Drugs / interventions tested
- Chelsea Critical Care Physical Assessment Tool
Conditions studied
- Post Intensive Care Unit Syndrome — all drugs for Post Intensive Care Unit Syndrome →
- Covid19 — all drugs for Covid19 →
Sponsor
Gaziosmanpasa Research and Education Hospital
Who can join
Adults 18 to 90, any sex, with Post Intensive Care Unit Syndrome or Covid19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present assessment tools for assessing physical function after intensive care unit (ICU) can be categorized as (1) functional tests (2) walk tests (3) strength test (4) Health-related quality of life (HRQOL). Strength tests such as Medical Research Council Scale and HRQOL (e.g. Short form-36 (SF-36) tests may require awakening and appropriate mental health. However, mental impairments were seen in a considerable number of patients (2). Walk tests such as Six-Minute Walk Test (6MWT) or Timed Up\&Go (TUG) can be impractical, some patients could not be able to perform these due to severe impairment. These tests require space to perform and may require management of several drips, drains, and oxygen delivery systems while the patient is walking and turning which render the test difficult to carry out. Among these three specific tools, CPAx seems to be the assessment tool that can be considered easy to use in the clinical setting due to the short time required for assessment and relatively minimal use of equipment (hand dynamometer for grip strength measurement). This study aims to investigate validation of Chelsea Critical Care Physical Assessment Tool in the assessment of the functional status of COVID patients discharged from ICU and investigate the feasibility of commonly used assessment tools for assessing physical function after ICU in COVID patients discharged from ICU.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04762056
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Post Intensive Care Unit Syndrome
Currently open trials in the same condition.
- NCT07496255 — Virtual Reality Cognitive Intervention for Critically Ill Delirium Survivors (VR-Cog) · NA · recruiting
- NCT05537298 — Muscle Recovery After Critical Illness · recruiting
- NCT04967365 — Post-Intensive Care Syndrome - Pediatrics (PICS-p): Longitudinal Cohort Study · active not recruiting
Other Gaziosmanpasa Research and Education Hospital trials
Trials by the same sponsor.
- NCT07459400 — The Effect of Peloidotherapy in Young Adults Undergoing Physical Therapy Scoliosis Specific Exercises (PSSE) · not yet recruiting
- NCT07366814 — Pipelle Versus Karman Endometrial Biopsy Under Standardized Paracervical Block · NA · completed
- NCT07372430 — Proximal Versus Distal Superior Cluneal Nerve Block in Entrapment Neuropathy · recruiting
- NCT07459413 — Oral vs. Intravenous Hydration to Prevent Contrast-Associated Acute Kidney Injury in the ED · NA · recruiting
- NCT07272213 — Thyroid-Stimulating Hormone Levels in Pregnancy and Their Association With Depression, Anxiety, and Sexual Function · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04762056 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gaziosmanpasa Research and Education Hospital
- Last refreshed: 11 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04762056.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing